Action BLUE BLUEBIRD BIO, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues bluebird bio, Inc.

Actions

BLUE

US09609G1004

Temps réel estimé Cboe BZX
Autres places de cotation
 16:06:41 20/05/2024 		Varia. 5j. Varia. 1 janv.
1,065 USD +3,40 % Graphique intraday de bluebird bio, Inc. +2,94 % -23,91 %
16/05 Transcript : Bluebird bio, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
09/05 Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
BLUE Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm
BLUE Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUE
Bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
Bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy
Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BLUE
  4. Actualités bluebird bio, Inc.
  5. Autres langues